cleveland clinic glp-1 Could medications help slow cancer progression?⁣ ⁣ A new study found those taking GLP-1s were less likely to develop stage IV disease in several cancer types, when compared to Gene Could Impact Weight Loss

That compares with 14.9% and 13.6% of patients who took a placebo in the two trials, respectively

:

Another placebo-controlled study 35 reported clinical improvement alongside circadian biomarker assessment, noting that seven participants had more than a 10-point decrease in DSM-III-R depression score after ALC treatment

Excluding the inherent limitations that are known to exist with dietary self-reports, we expressed caloric intake relative to body mass, and based on the fact that there were no significant changes over the course of the 8-week study for the dietary variables, and that GSH + CIT did not consume more total calories or protein than the other two groups, dietary intake can likely be ruled out as a possible confounding variable for the increased lean mass